PAPACKS: 100-Million Coffee Capsule Deal: PAPACKS and EURO-CAPS Conquer the Market with Plastic-Free Innovation and Win the Prestigious WorldStar Packaging Award
The coffee capsule, developed together in a more than five-year fantastic collaboration between Euro-Caps and PAPACKS, is made from renewable, FSC®-certified raw materials, representing a significant advancement in the sustainable packaging industry. It greatly minimizes waste and optimizes resource usage.

These innovative oil-resistant and water-resistant fiber-based coffee capsules ensure coffee freshness and enable smooth use in capsule coffee machines, significantly reducing environmental impact, in line with our principles of social responsibility and circular economy.
With great pride and joy, we announce that PAPACKS and Euro-Caps have been awarded the esteemed WorldStar Packaging Award 2024 for their innovative fiber-based coffee capsule. This honor from the World Packaging Organization (WPO) recognizes our ongoing commitment to sustainability and high-quality standards.
With this step and the expansion to other compatible capsule models, Euro Caps, in collaboration with PAPACKS, becomes one of the first industrial-scale suppliers of a functioning fiber-based coffee capsule, which can significantly reduce the current use of plastic and aluminum capsules. According to calculations by DUH (Deutsche Umwelthilfe [https://www.duh.de/]), Germans consumed a total of 3.4 billion coffee capsules in 2019, equating to approximately 13,500 tons of waste.
The joint development with Euro-Caps and PAPACKS challenged numerous experts from both companies to ensure the final product functions flawlessly, especially in its properties of oil resistance and water resistance, completely without plastic and aluminum. This innovation in design and technology has been registered as an international design patent with the World Intellectual Property Organization (DM/230736).
Tahsin Dag, Founder & CEO of PAPACKS, comments:
"We are proud of our developments in coffee capsules, demonstrating our commitment to environmental protection and sustainability. Transforming rapidly renewable, FSC®-certified raw materials into compostable capsules represents a significant advancement. Our innovative and outstanding collaboration with EURO-CAPS has been instrumental in achieving these innovations. This partnership emphasizes our mission to advance eco-friendly packaging solutions and to serve both our customers and the environment."
Anthony Kay, R&D Engineer at EURO-CAPS, comments:
"The advancements we have made at EURO-CAPS in the development of coffee capsules are a clear indication of our innovative strength and commitment to the environment. Through our collaboration with PAPACKS, we have succeeded in developing capsules that are not only environmentally friendly but also technologically advanced. Our focus was on creating a capsule that is fully compostable without compromising on the quality and taste experience of the coffee. This is a significant step forward for sustainability in the coffee capsule industry."
We thank our dedicated development and production team, as well as all involved partners, for their devoted work. The award will be honored at the WorldStar Awards Ceremony and Gala Dinner in Bangkok, Thailand, on June 15, 2024.
For more information, please visit:
https://www.papacks.com/en/worldstar-packaging-award-2024/
About the World Packaging Organisation (WPO)
The World Packaging Organisation (WPO) is a non-profit, international association founded in 1968. It brings together national and regional packaging institutes and associations, as well as companies and trade associations. Its main goal is to promote packaging technology, science, and education. The WPO supports the development of international trade and educational programs in the packaging sector through conferences, activities, publications, and an international award program for packaging design. With 84 members from 63 countries, the WPO is strongly committed to innovations in packaging. www.worldpackaging.org
About Euro-Caps Holding B.V.
Euro-Caps is a leading global provider of private label coffee capsules, especially since the market opened up for Nespresso®-compatible products in 2012. With a dedicated team, Euro-Caps operates two plants producing millions of capsules daily for Nespresso® and Dolce Gusto®. The company has extensive expertise in coffee and packaging, reflected in the quality of their products and services. Euro-Caps places great emphasis on the entire value chain, from bean sourcing to final customer delivery, supplying around 40 countries worldwide.
www.euro-caps.nl
About PAPACKS
PAPACKS is one of the leading European manufacturers of plastic-free, sustainable fiber-cast packaging solutions. They produce plastic-free packaging for industries such as food, beauty, pharma, as well as industrial applications for transportation and logistics. Utilizing rapidly renewable resources, they can combine these for higher requirements with plant-based coatings developed from their own research. These packaging solutions are suitable for modern circular economy concepts and offer alternatives to plastic packaging. PAPACKS offers an extensive portfolio, facilitating customers' transition to sustainable packaging. The company primarily manufactures in Germany, but also operates plants in the Netherlands and has offices in Prague, New York, and its headquarters in Cologne. www.papacks.com
Press contact / Inquiries
Manuel Leibrock, PAPACKS / CMO, presse@papacks.com
Images


Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
INTERSPORT Austria acquires INTERSPORT Slovenia Group15.1.2026 15:16:10 CET | Press release
Strategic move strengthens market position in Central Europe, with over 500 locations in 12 countries and more than € 1 billion in sales
VORN Bioenergy announces appointments to leadership team15.1.2026 11:14:45 CET | Press release
Regensburg. VORN Bioenergy today announces the appointment of Jörg Lennertz as Chief Executive Officer and Manuel Fernández Durán as Chief Financial Officer. Jörg and Manuel together with Michael Wallis Olausson form the new management team.
Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release
Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions
ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner13.1.2026 09:00:00 CET | Press release
Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom